Marc de Garidel

Marc de Garidel is a French businessman.[1] He serves as the non-executive chairman of the pharmaceutical company Ipsen and advises Mayroy, the Ipsen controlling holding company.[1][2][3][4][5]

Biography

Early life

Marc de Garidel graduated from the École Spéciale des Travaux Publics, an engineering grandes écoles in Paris.[1][3][4] He received business degrees from the Thunderbird School of Global Management in Glendale, Arizona and the Harvard Business School.[1][3][4]

Career

In 1983, he started his career at Eli Lilly and Company, where he worked in France, the United States and Germany.[1][3]

In 1995, he joined Amgen as Vice President, of Finance and Treasury for Europe.[1][3][4] In 1998, he became Vice President, Corporate Controller and Chief Accounting Officer of Amgen.[1][3] In 2000, he became Vice President and General Manager for France, in charge of Amgen France.[1][3] In 2006, he became Vice President for Southwestern Europe, including France, Spain, Belgium and Portugal.[1][3] From 2007 to 2010, he served as Vice President for Southern Europe, the Middle East, Asia and Latin America at Amgen.[1][3][4]

He has served as Chairman and CEO of Ipsen since November 2010.[1][3][4][5] He sits on the Board of Directors of TcLand Expression.[1] He is also Chairman of the Board of Promethera Biosciences and European Biopharmaceutical Entreprises.[1][4]

He is President and spokesperson for G5 santé, a lobbying group for French pharmaceutical companies, including BioMérieux, Guerbet, Ipsen, the Laboratoire français du Fractionnement et des Biotechnologies, Laboratoires Pierre Fabre, Sanofi, Stallergenes and Laboratoires Théa.[5]

The Board of Directors of Ipsen has appointed David Meek as Chief Executive Officer, effective July 18, 2016.[2] On this date, Marc de Garidel will assume the role of non-executive chairman and will continue to serve the Board of Directors through his deep industry expertise. In addition, Marc de Garidel will advise Mayroy, the Ipsen controlling holding company.[6]

He is a Knight in the National Order of the Legion of Honour.

Bibliography

  • La Société du Médicament (2006)

References

  1. 1 2 3 4 5 6 7 8 9 10 11 12 13 "Marc M.P. de Garidel: Executive Profile & Biography". Bloomberg. Retrieved 4 November 2016.
  2. 1 2 "(David Meek new CEO of Ipsen)" (PDF). Archived from the original (PDF) on 2016-09-23.
  3. 1 2 3 4 5 6 7 8 9 10 "Ipsen biography". Archived from the original on 2013-04-11.
  4. 1 2 3 4 5 6 7 "Management". Promethera Biosciences. Board of Directors & and (sic) founders. Archived from the original on 11 October 2014.
  5. 1 2 3 "Les membres du G5 santé" [The G5 Health] (in French). G5 Health.
  6. ↑ "David Meek appointed as Chief Executive Officer of Ipsen" (Press release). Ipsen. 11 July 2016 – via Business Wire.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.